Elizabeth Anderson
Stock Analyst at Evercore ISI Group
(1.12)
# 1824
Out of 5,328 analysts
128
Total ratings
41.82%
Success rate
-9.49%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
TDOC Teladoc Health | Maintains: In-Line | 8 7 | 6.84 | 2.34% | 3 | May 1, 2025 | |
ALGN Align Technology | Maintains: Outperform | 165 200 | 182.51 | 9.58% | 13 | May 1, 2025 | |
DGX Quest Diagnostics | Maintains: In-Line | 175 180 | 178.31 | 0.95% | 3 | Apr 23, 2025 | |
HCAT Health Catalyst | Downgrades: In-Line | 6 4 | 4.01 | -0.25% | 6 | Apr 9, 2025 | |
FTRE Fortrea Holdings | Maintains: In-Line | 20 15 | 6.34 | 136.59% | 7 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 650 675 | 709.5 | -4.86% | 5 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 60 65 | 71.27 | -8.8% | 6 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: In-Line | 9 12 | 10.96 | 9.49% | 13 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 260 265 | 241.92 | 9.54% | 4 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | 20 | 14.19 | 40.94% | 7 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 140 140 | 145.5 | -3.78% | 6 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 32 36 | 39.22 | -8.21% | 4 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 270 265 | 154.55 | 71.47% | 5 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: In-Line | 34 45 | 58.61 | -23.22% | 7 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: In-Line | 7 4 | 4 | 0% | 4 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 18 23 | 16.52 | 39.23% | 3 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 23 20 | 23.17 | -13.68% | 3 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 5 5 | n/a | n/a | 3 | Apr 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | 12 16 | n/a | n/a | 2 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | 25 39 | n/a | n/a | 2 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 185 | n/a | n/a | 9 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 7 5 | n/a | n/a | 1 | Sep 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | 11 12 | n/a | n/a | 2 | Jul 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: In-Line | 68 27 | 10.3 | 154.85% | 3 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | 35 15 | 5.65 | 165.49% | 3 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | 11 | 3.25 | 238.46% | 2 | Jan 4, 2022 |